3/16/2021Patent Term Extension in China

3/15/2021NMPA Announces OTC Switch of Miconazole Nitrate Vaginal Tablets

3/15/2021NHC Issues the 2nd Batch of Its List of Encouraged Generic Drugs

3/15/2021Highlights of the 14th Five Year Plan Covers Various Aspects of Health...

3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes

3/12/2021Recent Executive Moves

3/12/2021CDE Issues the Technical Guidelines for Pharmaceutical Changes During ...

3/12/2021NHC Issues the Pediatric Vaccine Inoculation Procedures and Notes of t...

3/11/2021Bayer's Chinese NDA for PI3K Inhibitor Copanlisib Accepted by the CDE

3/11/2021NHSA Initiates DRG-based Medical Insurance Payment in Simulation Run

3/11/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (4...

3/10/2021Alphamab's IND for Phase II Pivotal Trial of KN046 Cleared in the U.S...

3/10/2021Eirion Therapeutics Closes $40M Series A Investment and Licensing Deal...

3/10/2021Wugen Enter Partnership with Alpha Biopharma in Asia for Cell Therapie...

3/10/2021Uni-Bio Science and DotBio Announce Partnership to Co-Develop Multi-s...

3/10/2021I-Mab Signs Two New Partnerships to Expand Transformational I/O Pip...

3/10/2021ReForm Biologics Announces the Issuance of Chinese Patent for Therapeu...

3/10/2021Multi-source Financing for Tuberculosis Treatment in China: Key Issues...

3/10/2021I-Mab BioPharma and Its Dual Drug Portfolio

3/9/2021Sinopharm Faces Battle to Turn Covid Vaccine into a Global Success

3/9/2021CNIPA Releases Chinese IP Related Statistics in 2020

3/9/2021NHSA Holds Conference, Highlighting Path Forward for Centralized Drug ...

3/9/2021Huyabio's Chinese JV Submits NDA of Topical Efinaconazole in China

3/9/2021Abbisko Therapeutics Eyes $250M in Planned Hong Kong IPO

3/9/2021ReViral and LianBio Enter License Pact for Sisunatovir in China

3/9/2021Junshi's IND for Bifunctional Fusion Protein Accepted in China

3/8/2021CDE Issues the Requirements for Preclinical Study Drugs Marketed Outsi...

3/8/2021Sorrento's Socazolimab Cleared for Late-Stage Lung Cancer Study in Chi...

3/8/2021CDMO Vetter Opens Office in China to Meet Growing Demands

3/8/2021CASI Pharma and Cleave Therapeutics Strike a Licensing Agreement for C...

Page:140/719 Total number of articles:21555: [First][<<] [138] [139] [140] [141] [142] [>>] [End]